Announcements
- Final Results
- Total Voting Rights
- Placing to Raise US$4.2 million
- FDA Consents to Phase I Trials of HEMO-CAR-T
- Approval and Issuance of U.S. Conditioning Patent
- Submission of Complete Response to Clinical Hold
- HEMO-CAR-T Process Qualification Run Completed
- Placing to Raise £534,375
- CBR Expanded to Treatment of Cancer
- Lentivirus Re-manufacturing Completed
More ▼
Key statistics
On Thursday, Hemogenyx Pharmaceuticals PLC (5HU:DEU) closed at 0.013, 62.50% above the 52 week low of 0.008 set on Jun 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.015 |
---|---|
High | 0.015 |
Low | 0.013 |
Bid | 0.011 |
Offer | 0.0235 |
Previous close | 0.013 |
Average volume | 4.00k |
---|---|
Shares outstanding | 1.34bn |
Free float | 1.20bn |
P/E (TTM) | -- |
Market cap | 19.99m GBP |
EPS (TTM) | -0.0061 GBP |
Data delayed at least 15 minutes, as of May 16 2024.
More ▼